Planning and Feasibility · Usability Engineering (IEC 62366-1)
Engineer IEC 62366-1 & FDA Human Factors usability evidence that withstands regulatory scrutiny.
Global reviewers (FDA CDRH, EU Notified Bodies, MFDS) audit the entire lifecycle chain: Use Specification, Known Use Problems, PCA task analysis, Use-Related Risk Analysis (URRA) linked to ISO 14971, formative design iterations, summative validation (N≥15 per group), and Root Cause Analysis (RCA).
Domain Expertise
Deep regulatory authority across every medical device domain
SaMD · AI Digital Health
IEC 62304 & IEC 82304-1 Software Lifecycle · FDA PCCP & Good Machine Learning Practice
Multi-demographic dataset bias control and statistical validation design for Sensitivity, Specificity, and ROC-AUC
Active Devices · Robotics
IEC 60601-1 Ed. 3.2 & IEC 60601-1-2 Ed. 4.1 · IEC 60601-2-XX Particular Standards
Essential Performance definition and worst-case test matrix optimization across FDA, EU Notified Bodies, and MDSAP
Implants · Biomaterials
ISO 10993-1:2018 & ISO 10993-18 E&L · ISO 11135 / 11137 Sterilization & ISO 11607
Biological evaluation plans (BEP), ISO 10993-18 chemical characterization, and toxicological risk assessment (TRA)
In Vitro Diagnostics (IVD)
EU IVDR 2017/746 & FDA IVD Guidance · CLSI EP Guidelines (EP05, EP06, EP12, EP17, EP25)
CLSI-compliant Limit of Detection (LoD), precision, cross-reactivity, interference, and lot-to-lot reproducibility protocols
Proprietary Data & Precedent Validation
PCA Use-Error Hazard Library & Global Summative Protocol Benchmark DB
100% Traceability Across uFMEA Critical Tasks, ISO 14971 Controls & Summative Validation
Engineered 4-Stage Workflow
4-Stage Human Factors Pipeline from Use Spec to Summative UEF Delivery
Use Specification, Task Analysis, uFMEA & Critical Tasks Locked
Incomplete baseline data or misclassified regulatory pathways are the primary drivers of multi-month submission delays. Gate 01 locks the device scope, predicate/standard mapping, and full document inventory before authoring begins.
Verification Baseline
Device description, intended use, existing test reports, and QMS document index
Gate Sign-Off Output
Confirmed classification matrix and locked submission master inventory
Agentic Automation & Platform Integration
Synchronize Usability Risk Controls with ISO 14971 & Multi-Language eIFU
Bi-Directional Sync: uFMEA Critical Tasks ↔ ISO 14971 Risk File
Maintains a single source of truth between use-related hazards, severity ratings, UI design mitigations, and summative verification evidence.
@Risk Management— Run "Bi-Directional Sync: uFMEA Critical Tasks ↔ ISO 14971 Risk File" across our Usability Engineering (IEC 62366-1) records and call out the highest-priority compliance findings first.
I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.
Thought for 4.2s · Explored Risk Management records & 14 regulatory clauses
Maintains a single source of truth between use-related hazards, severity ratings, UI design mitigations, and summative verification evidence. ISO 14971 risk register linked to design control
Audit-Ready Formative & Summative Observation Logs
Preserves participant task outcomes, close-call annotations, and Root Cause Analysis (RCA) narratives in a traceable digital repository.
@Requirements Management— Run "Audit-Ready Formative & Summative Observation Logs" across our Usability Engineering (IEC 62366-1) records and call out the highest-priority compliance findings first.
I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.
Thought for 4.3s · Explored Requirements Management records & 14 regulatory clauses
Links summative-validated IFU instructions and warnings directly to Leanabl eIFU workflows to prevent unvalidated labeling edits. Traceability from specification to verification
Service Specification
Service Scope & Final Deliverables
Scope
Covers the entire human factors lifecycle from use-related risk analysis (uFMEA) to formative and summative validation reporting.
- Use Specification authoring — user profiles, use environments, and primary operating functions
- Task Analysis, PCA (Perception-Cognition-Action) use-error hazard analysis (uFMEA), and Critical Task identification
- Bi-directional traceability between ISO 14971 risk controls and UI/alarm/IFU design mitigations
- Formative evaluation and Summative human factors validation protocol engineering (aligned with IEC 62366-1 & FDA HFE guidance)
- Simulated-use study execution, Root Cause Analysis (RCA) of use errors/close calls, and final HFE/UER report compilation
Deliverables
Audit-ready Usability Engineering Files structured for FDA eSTAR, EU MDR Notified Bodies, and global submissions.
- Usability Engineering Plan (UEP) & Use Specification Document
- Use-Related Risk Analysis (uFMEA) & Critical Task Selection Matrix
- Formative & Summative Validation Protocols, Moderator Guides, and Data Capture Forms
- Observed Use Error, Close Call & Root Cause Analysis (RCA) Dossier
- Final Usability Engineering Report (UER / FDA HFE/UE Report) & ISO 14971 Traceability Matrix
| Category | Item / Milestone | Specification & Deliverable |
|---|---|---|
| Scope | Scope 1 | Use Specification authoring — user profiles, use environments, and primary operating functions |
| Scope | Scope 2 | Task Analysis, PCA (Perception-Cognition-Action) use-error hazard analysis (uFMEA), and Critical Task identification |
| Scope | Scope 3 | Bi-directional traceability between ISO 14971 risk controls and UI/alarm/IFU design mitigations |
| Scope | Scope 4 | Formative evaluation and Summative human factors validation protocol engineering (aligned with IEC 62366-1 & FDA HFE guidance) |
| Scope | Scope 5 | Simulated-use study execution, Root Cause Analysis (RCA) of use errors/close calls, and final HFE/UER report compilation |
| Workflow | Stage 1: Use Specification & Use-Related Risk Analysis (uFMEA) | Define intended user groups and environments, decompose tasks, and identify hazard-related use scenarios (Critical Tasks). |
| Workflow | Stage 2: Formative Evaluation & UI Risk Mitigation | Conduct cognitive walkthroughs and formative usability testing to refine hardware/software UI and labeling before design freeze. |
| Workflow | Stage 3: Summative Validation Protocol & Simulated-Use Testing | Lock the summative validation protocol and execute simulated-use testing across representative user cohorts. |
| Workflow | Stage 4: Root Cause Analysis (RCA) & Master UEF Delivery | Analyze any observed use errors or close calls, justify residual use-related risk, and compile the final UEF / HFE Report. |
| Deliverables | Deliverable 1 | Usability Engineering Plan (UEP) & Use Specification Document |
| Deliverables | Deliverable 2 | Use-Related Risk Analysis (uFMEA) & Critical Task Selection Matrix |
| Deliverables | Deliverable 3 | Formative & Summative Validation Protocols, Moderator Guides, and Data Capture Forms |
| Deliverables | Deliverable 4 | Observed Use Error, Close Call & Root Cause Analysis (RCA) Dossier |
| Deliverables | Deliverable 5 | Final Usability Engineering Report (UER / FDA HFE/UE Report) & ISO 14971 Traceability Matrix |
Frequently Asked Questions
When should usability engineering start?
Do you review both formative and validation evidence?
Do you recruit participants or run studies?
Which standards and markets do you cover?
How does Leanabl handle agency Additional Information (AI) requests or Notified Body deficiency letters during Usability Engineering (IEC 62366-1)?
Can we structure one master DHF / IMDRF STED and test campaign to cover FDA, EU MDR, and APAC markets simultaneously?
We have a lean internal RA/QA team—how much bandwidth is required from our R&D engineers?
What happens if our hardware, firmware, or software changes during or after the engagement?
Make the usability file reviewable before the reviewer sees it.
We separate missing evidence, weak traceability, and follow-on study work so the next step is clear before submission.